Banook Group   Report issue

For profit Phase 1 Phase 3
Founded: Nancy France (1999)

Organization Overview

First Clinical Trial
2010
NCT01258816
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Banook Group | CardiaBase | Cardiabase, Banook Group

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Malaria (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 8